Navigation Links
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label
Date:6/8/2011

ed in pregnant or nursing women.
  • about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Your Humalog dose may need to change if you take other medicines because they may:
    • change your risk for low blood sugar (hypoglycemia) or high blood sugar (hyperglycemia).
    • keep you from having symptoms when your blood sugar is low.

  • How should I use Humalog?  

    • Humalog can be used with a syringe, prefilled pen, reusable pen, or external insulin pump. Read the instructions for use that come with your Humalog product. Your healthcare provider should show you how to inject Humalog before you start taking it.
    • Humalog is a rapid-acting insulin. You should take Humalog within fifteen minutes before eating or right after eating a meal.
    • Only use Humalog that is clear and colorless. If your Humalog is cloudy, colored, or has solid particles or clumps in it, return it to your pharmacy for a replacement.
    • Do not mix Humalog with any type of insulin other than NPH when used with injections by syringe or with any other insulin or liquid when used in a pump.
    • If your doctor recommends diluting Humalog (that is, a smaller number of units of Humalog for a certain amount of liquid), follow your doctor's instructions exactly. Do not use diluted insulin in a pump.
    • Inject Humalog under your skin (subcutaneously) in your upper arm, abdomen (stomach area), thigh (upper leg), or buttocks. Never inject it into a vein or muscle. Change (rotate) your injection site with each dose.
    • If you have type 1 diabetes, you need to take a longer-acting insulin in addition to Humalog (except when using an external insulin pump).
    • I
      '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. FDA Approves Marketing of RMS Subcutaneous Needle Sets
    2. FDA Approves Injectable Gel to Treat Fecal Incontinence
    3. FDA approves Incivek for hepatitis C
    4. FDA Approves Sutent for Rare Type of Pancreatic Cancer
    5. FDA Approves New HIV Treatment
    6. FDA Approves Victrelis for Hepatitis C
    7. FDA Approves New Treatment for Rare Type of Pancreatic Cancer
    8. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
    9. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
    10. FDA Approves New Treatment for Type 2 Diabetes
    11. FDA Approves Zytiga for Late-Stage Prostate Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... , Oct. 22, 2014  Rescheduling of hydrocodone ... in the pain market, according to a new ... a firm providing market research and consultation exclusively ... Photo - http://photos.prnewswire.com/prnh/20141021/153440 ... for hydrocodone combination products from Schedule III to ...
    (Date:10/22/2014)... , October 22, 2014 Investor-Edge ... Inc. (NASDAQ: FOLD ), Progenics Pharmaceuticals Inc. ... THLD ), Idera Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... 21, 2014, the NASDAQ Composite ended at 4,419.48, up ...
    (Date:10/22/2014)... , Oct. 22, 2014  Charlene Vernak, RPh, of ... , recently was awarded the George Roentsch Scholarship ... received the award in Houston ... scholarship is awarded annually to an independent pharmacist and ... of George Roentsch , a well-known pharmacist in ...
    Breaking Medicine Technology:Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2
    (Date:10/22/2014)... Healthcare professionals who are looking ... at home or on-the-go via laptops, tablets or ... new, premium Seminar-on-Demand CE courses. The new courses ... 2,000 hours of CE course offerings, allowing ... With such a diverse library, there’s something for ...
    (Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
    (Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... of conventional in vitro fertilization (IVF) -- the incubation of ... in a device inside the vagina, new research suggests. ... device, called an INVOcell, might sharply cut costs for pricey ... technology more accessible to those who don,t live near big-city ...
    (Date:10/20/2014)... Florida (PRWEB) October 20, 2014 With ... former Gov. Charlie Crist made a brief fundraising stop ... Orlando on Thursday. , Fresh from a debate last ... to take the stage for the first seven minutes ... the former governor described the incident in one word: ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 T.E.N., ... relationship-marketing firm, announced today that William H. Murray, ... the 2014 ISE® Luminary Leadership Award winner. Presented ... achievements of an outstanding leader and industry practitioner ... contributions in advancing the information security industry. , ...
    Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
    ... study in the Aug. 1 issue of the journal Sleep ... infants are easier to arouse than females during quiet sleep, and ... gender differences in arousability. The results suggest that the increased ... reflect a pre-existing vulnerability involving arousal responses. Results show that ...
    ... Teenage years have long been linked with a heightened ... and tout happiness as just a nip/tuck away. A RutgersCamden ... programs are more likely to join the millions who go ... - still in development, these drastic decisions could have implications ...
    ... LANSING, Mich. - With the help of a $2.5 ... State University is creating a cross-discipline, mentored program designed ... women,s health., MSU,s new Building Interdisciplinary Research Careers in ... of Medicine in the College of Human Medicine, will ...
    ... strain, ST131, was a major cause of serious antimicrobial-resistant ... researchers found. This strain has been reported in multiple countries ... study, researchers analyzed resistant E. coli isolates collected ... 54 ST131 isolates, which accounted for 67 percent to 69 ...
    ... CD74 is a protein that is expressed in and ... lymphocytes and antigen presenting cells. This protein is known ... immune response. Additionally, Professor Shachar,s lab has previously shown ... of the immune system, and that its stimulation by ...
    ... refers to a group of disorders characterized by ... bile ducts. Multiple causes have been identified including ... medications. The usual course of this condition is ... treatment of the underlying condition and/ or removal ...
    Cached Medicine News:Health News:SIDS surprise: Study finds that infant boys are more easily aroused from sleep than girls 2Health News:SIDS surprise: Study finds that infant boys are more easily aroused from sleep than girls 3Health News:Reality TV, cosmetic surgey linked, says Rutgers-Camden researcher 2Health News:MSU targets women's health research with $2.5 million grant 2Health News:Vanishing bile duct syndrome secondary to anti-retroviral therapy in HIV 2
    For the rapid determination of human chorionic gonadotropin (hCG) in urine. The test strip is used to obtain a visual qualitative result....
    ... GE Healthcares new Vivid i ... cardiovascular ultrasound system to provide high-performance, full-featured ... Vivid i addresses one ... access to complete, real-time diagnostic information. ...
    ... is an immunochromatographic in vitro assay for ... in human serum or plasma. Elevated concentration ... pathologies. It may also be caused by ... of IgE using InstaTest IgE test kit ...
    ... Through its unique and patented ... wires and trunk cables between patients ... monitors, allowing freedom of movement throughout ... technology, the LifeSync(R) System employs two-way ...
    Medicine Products: